The emerging approach of tirzepatide peptide represents a major development in the management of diabetes mellitus type 2. Unlike existing therapies, tirzepatide affects two pathways – GLP-1 and the GIP hormone – https://tirzepatide-peptide347334.bloggip.com/42531067/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment